PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY

becoming increasingly widespread evaluation of the blood-brain barrier (BBB) resistance to predict severity and outcome of epilepsy, stroke, traumatic brain injury (TBI) and other neurological disorders by assessment of neuron-specific proteins (NSP)  concentration in biological fluids. In this work...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yazar: D. V. Blinov
Materyal Türü: Artigo
Dil:Russo
Baskı/Yayın Bilgisi: IRBIS LLC 2015-03-01
Seri Bilgileri:Фармакоэкономика
Konular:
cns
bbb
neuron-specific proteins
nsp
neuron-specific enolase
nse
glial fibrillary acid protein
gfap
Online Erişim:https://www.pharmacoeconomics.ru/jour/article/view/119
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller